Author Archives: donttradeourlivesaway

The RCEP and Trans-Pacific Intellectual Property Norms

Vanderbilt Journal of Transnational Law, Vol. 50, 2017 Forthcoming; Texas A&M University School of Law Legal Studies Research Paper No. 16-50 Abstract: In the past few years, the Trans-Pacific Partnership has garnered considerable media, policy and scholarly attention. Rarely analyzed … Continue reading

Posted in IPR, Regional Comprehensive Economic Partnership, TPP, TRIPS plus, Uncategorized | Leave a comment

Call for Govt to help our neighbours negotiate for life-saving medicines

Source: Trade talks for the proposed Regional Comprehensive Economic Partnership (RCEP) continue this week in China. The trade deal includes a chapter on intellectual property that health organisations say could threaten countries’ access to life-saving medicines.

Posted in Regional Comprehensive Economic Partnership, Uncategorized | Leave a comment


The organisation T1International is calling for insulin and other vital diabetes supplies to be made available for everyone with diabetes through their Type 1 Diabetes Access Charter. Around the globe today, millions of people with type 1 diabetes are dying because they cannot afford or … Continue reading

Posted in Uncategorized | Leave a comment

India to US: Will not tighten IPR rules beyond TRIPS mandate

Commerce Minister Nirmala Sitharaman demands food safety clearance mechanism during talks with US Trade Representative Source: The Hindu BusinessLine | October 20, 2016 India and the US continued to differ on the issue of intellectual property rights (IPR) norms at … Continue reading

Posted in Compulsory Licensing, Data Exclusivity, Evergreening, IPR, Patent linkage, Sec 3 (d), TRIPS, TRIPS plus, Uncategorized, UNHLP report, USTR 301 report | Leave a comment

Our view on India and US Joint Statement on the Trade Policy Forum Delhi – October 20, 2016

In the recently concluded US India Trade Policy Forum meeting held in Delhi, both countries laid emphasis on the importance of having a robust and balanced IPR protection in fostering creativity, promoting innovation, and attracting investment. Indian government was praised … Continue reading

Posted in IPR, IPR policy, TRIPS plus, Uncategorized | Leave a comment

RCEP patent clauses lack compassion says Public Health Association

Public Health Association media release 21 October 2016 The Public Health Association of New Zealand (PHA) is calling on New Zealand Government negotiators to oppose clauses in the Regional Comprehensive Economic Partnership (RCEP), currently being negotiated, that would increase the … Continue reading

Posted in Data Exclusivity, Patent, Patent Term Extension, Regional Comprehensive Economic Partnership, Uncategorized | Leave a comment

UN High Level Panel report is good prescription for change in access to medicines

Source: PharmaLetter | October 18, 2016 In our weekly expert view piece, Rohit Malpani, director of policy and analysis for Mèdecins Sans Frontiéres Access Campaign, discusses the UN Secretary General’s High-Level Panel report on Access to Medicines and looks at the … Continue reading

Posted in Delinkage, R&D, TPP, TRIPS, TRIPS flexibilities, TRIPS plus, Uncategorized | Leave a comment